SantoSolve raises USD 5.5 million
The Norwegian biotech company SantoSolve has completed a new round of financing, and managed to raise USD 5.5 million.
Contributions have been made by existing investors Teknoinvest, Investinor and InnovationsKapital, and new investors include DnBNor, Gezina and Glastad Invest. The funding will enable further advancements in the development of SantoSolves lead product 2PX.
Read more
| Fund | Teknoinvest VIII KS Argentum share 32.43% |
| Portfolio Company | SantoSolve |
| Date of Transaction | 2007-11-09 |
| Transaction | Finance round |
| Seller | |
| Buyer | Teknoinvest VIII KS |
| Size of Transaction | USD 5.5m |
| Ind. Focus | Life Science |
| Geography | Norway |
| Stage | Venture |